← Back to Clinical Trials
Recruiting NCT07230743

NCT07230743 The Study Evaluates the Effect of an Interactive Projector as a Distraction for Children During Anesthetic Induction. The Primary Objective is to Reduce Perioperative Anxiety, Measured With the Modified Yale Preoperative Anxiety Scale (mYPAS).

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07230743
Status Recruiting
Phase
Sponsor Clinica Alemana de Santiago
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-07-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 6 Years
Study Type INTERVENTIONAL
Interventions
Custom projector-based video game intervention (BERT; Stanford Chariot Program, Palo Alto, CA)Standard Parent-Present Induction (PPI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2025-07-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed to evaluate the effect of technology as a distraction technique during anesthetic induction in children, starting from their arrival to the operating room. An interactive film will be displayed using a projector (BERT: Bedside Entertaining and Relaxation Tool) mounted on a whiteboard in front of the child's gurney. The primary outcome is perioperative anxiety, measured with the Modified Yale Preoperative Anxiety Scale (mYPAS).

Eligibility Criteria

Inclusion Criteria: * Patients undergoing elective procedures under general anesthesia at Clinica Alemana * Parent or caregiver presence for mask induction * ASA I, II * Ages 2-6 years of age * Spanish speaking * Parental consent/patient assent Exclusion Criteria: * Patient or parental does not consent * ASA ≥ III * Emergency surgery * Intravenous induction of anesthesia * Patient with a significant neurological condition or major developmental disability * Severe visual or auditory defects * Patients admitted using a crib as the mode of transport

Contact & Investigator

Central Contact

Ximena Mora Diez, MD

✉ xmora@alemana.cl

📞 +569 95377637

Frequently Asked Questions

Who can join the NCT07230743 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 6 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07230743 currently recruiting?

Yes, NCT07230743 is actively recruiting participants. Contact the research team at xmora@alemana.cl for enrollment information.

Where is the NCT07230743 trial being conducted?

This trial is being conducted at Vitacura, Chile.

Who is sponsoring the NCT07230743 clinical trial?

NCT07230743 is sponsored by Clinica Alemana de Santiago. The trial plans to enroll 70 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology